Try

Regencell Bioscience Holdings Ltd

RGCUnited States

8 filed reports · 272 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

8 reports · Jun 2021 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 25 commentary passages, 49 interim figures.

Report typeReportsFactsPeriods
Annual · 20-FSEC EDGAR61,192Jun 2021 to Jun 2026
Interim · 6-KSEC EDGAR2147Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY202620-FJun 30, 2026Oct 7, 2026385Open
FY2026 Q26-KDec 31, 2025May 8, 202634Open
FY2026 Q26-KDec 31, 2025May 8, 2026113Open
FY202520-FJun 30, 2025Oct 31, 2025179Open
FY202420-FJun 30, 2024Oct 25, 2024169Open
FY202320-FJun 30, 2023Oct 27, 2023156Open
FY202220-FJun 30, 2022Oct 31, 2022183Open
FY202120-FJun 30, 2021Oct 29, 2021120Open

Financial data

272 concepts · 1,339 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial261 concepts · 1,295 facts · Jun 2019 to Jun 2026

  • Cash cash equivalents restricted cash and restricted cash equivalents18 · Jun 2019 to Jun 2026
  • Stockholders equity including portion attributable to noncontrolling interest18 · Jun 2019 to Jun 2026
  • Deferred tax assets operating loss carryforwards16 · Jun 2019 to Jun 2026
  • Deferred tax assets valuation allowance16 · Jun 2019 to Jun 2026
  • Share based compensation arrangement by share based payment award options outstanding weighted average exercise price16 · Jun 2021 to Jun 2026
  • Stockholders equity (US GAAP)16 · Jun 2019 to Jun 2026
  • Accrued liabilities current15 · Jun 2020 to Jun 2026
  • Accumulated depreciation depletion and amortization property plant and equipment15 · Jun 2020 to Jun 2026
  • Assets15 · Jun 2020 to Jun 2026
  • Assets current15 · Jun 2020 to Jun 2026
  • Assets noncurrent15 · Jun 2020 to Jun 2026
  • Common stock par or stated value per share15 · Jun 2020 to Jun 2026
  • Common stock shares authorized15 · Jun 2020 to Jun 2026
  • Common stock shares issued15 · Jun 2020 to Jun 2026
  • Common stock shares outstanding15 · Jun 2020 to Jun 2026
  • Common stock value15 · Jun 2020 to Jun 2026
  • Deposits assets noncurrent15 · Jun 2020 to Jun 2026
  • Liabilities15 · Jun 2020 to Jun 2026
  • Liabilities and stockholders equity15 · Jun 2020 to Jun 2026
  • Liabilities current15 · Jun 2020 to Jun 2026
  • Property plant and equipment net15 · Jun 2020 to Jun 2026
  • Retained earnings accumulated deficit15 · Jun 2020 to Jun 2026
  • Sharebased compensation arrangement by sharebased payment award options nonvested weighted average grant date fair value14 · Jun 2021 to Jun 2026
  • Share based compensation arrangement by share based payment award options outstanding number14 · Jun 2021 to Jun 2026

Segment10 concepts · 40 facts · Jun 2023 to Jun 2026

  • Depreciation and amortization4 · Jun 2023 to Jun 2026
  • Net Income4 · Dec 2024 to Dec 2025
  • Net income loss4 · Jun 2023 to Jun 2026
  • Operating Expenses4 · Dec 2024 to Dec 2025
  • Operating expenses (US GAAP)4 · Jun 2023 to Jun 2026
  • Operating Income4 · Dec 2024 to Dec 2025
  • Operating income loss4 · Jun 2023 to Jun 2026
  • Other nonoperating income expense4 · Jun 2023 to Jun 2026
  • Selling and Marketing Expense4 · Dec 2024 to Dec 2025
  • Selling and marketing expense (US GAAP)4 · Jun 2023 to Jun 2026

Geography1 concepts · 4 facts · Jun 2019 to Jun 2022

  • Effective income tax rate continuing operations4 · Jun 2019 to Jun 2022

Segments

44 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments2 members · 40 facts

  • Consolidated24 · Jun 2023 to Jun 2026
  • Segment16 · Dec 2024 to Dec 2025

Statement geographical1 member · 4 facts

  • HK4 · Jun 2019 to Jun 2022

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Management discussion (MD&A) commentary25 claims from 1 reports · Jun 2026
  • Risk factors60 risks from 1 annual reports · 2026

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Regencell Bioscience Holdings Ltd (RGC) data · FactIQ